Search companies or stocks...
HROWHarrow Health, Inc.
At close · 02 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business;…
Current stock price of Harrow Health, Inc. (HROW) stock is $39.050. The stock price is +5.63% higher in the session. The intraday range can be seen from this page. Volume of Harrow Health, Inc. (HROW) stock is 468.32K.
Last updated at 02 Sept 2026, 08:00 pm.
The stock price of Harrow Health, Inc. (HROW) can change with earnings, company news, and overall market sentiment. Harrow Health, Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Harrow Health, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for HROW on this page is -39.44. EPS on this page is -0.99. Compare those figures with peers and growth expectations before deciding if the current Harrow Health, Inc. price is justified.
Historical performance for Harrow Health, Inc. (HROW) is shown on the price chart on this page. Review multi-period moves alongside volume to see how HROW reacted to past earnings and market events.
Buying Harrow Health, Inc. (HROW) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
